| Symbol | Company | Weighting |
|---|---|---|
| ABVX | ABIVAX SA | 24.50% |
| RVMD | REVOLUTION MEDICINES INC | 2.93% |
| EYPT | EYEPOINT INC | 2.64% |
| INSM | INSMED INC | 2.46% |
| EWTX | EDGEWISE THERAPEUTICS | 2.38% |
| CYTK | CYTOKINETICS INC | 2.36% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 2.07% |
| PCVX | VAXCYTE INC | 2.00% |
| IMVT | IMMUNOVANT INC | 1.93% |
| TVTX | TRAVERE THERAPEUTICS INC | 1.90% |
| TARS | TARSUS PHARMACEUTICALS | 1.85% |
| DYN | DYNE THERAPEUTICS, INC. | 1.84% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 1.74% |
| DNLI | DENALI THERAPEUTICS INC. | 1.72% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.69% |
| PSNL | PERSONALIS | 1.67% |
| GMED | GLOBUS MEDICAL INC CLASS A | 1.66% |
| AZN | ASTRAZENECA PLC | 1.63% |
| HCA | HCA HOLDINGS INC | 1.52% |
| MCK | MCKESSON CORP | 1.49% |
| HALO | HALOZYME THERAPEUTICS INC | 1.45% |
| THC | TENET HEALTHCARE CORP | 1.43% |
| CRNX | CRINETICS PHARMACEUTICALS INC | 1.37% |
| ARGX | ARGENX SE ADR | 1.36% |
| GKOS | GLAUKOS CORPORATION | 1.29% |
| ABBV | ABBVIE INC | 1.29% |
| TNDM | TANDEM DIABETES CARE INC | 1.22% |
| REGN | REGENERON PHARMACEUTICALS | 1.21% |
| MDT | MEDTRONIC PLC | 1.19% |
| DHR | DANAHER CORP | 1.18% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.13% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.12% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.11% |
| UNH | UNITEDHEALTH GROUP INC | 1.10% |
| RGEN | REPLIGEN CORP | 1.10% |
| RMD | RESMED INC | 1.08% |
| SYK | STRYKER CORP | 1.04% |
| BDX | BECTON DICKINSON & CO | 1.04% |
| ALC | ALCON INC | 1.01% |
| SNY | SANOFI- AVENTIS- ADR | 0.99% |
| ISRG | INTUITIVE SURGICAL INC | 0.96% |
| ABT | ABBOTT LABORATORIES | 0.95% |
| DXCM | DEXCOM INC | 0.93% |
| ADMA | ADMA BIOLOGICS, INC. | 0.90% |
| ELV | ELEVANCE HEALTH INC | 0.90% |
| KRRO | KORRO BIO | 0.89% |
| VCEL | VERICEL CORP | 0.89% |
| ICLR | ICON PLC | 0.85% |
| ZTS | ZOETIS INC | 0.82% |
| HUM | HUMANA INC | 0.81% |
| BSX | BOSTON SCIENTIFIC | 0.79% |
| SMMT | SUMMIT THERAPEUTICS INC. | 0.77% |
| SPRY | ARS PHARMACEUTICALS | 0.72% |
| CDXS | CODEXIS INC | 0.71% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.67% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.56% |
| LENZ | LENZ THERAPEUTICS | 0.52% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.42% |
| WAT | WATERS CORP | 0.26% |
| AKROCV | CONTRA AKERO THERAPEUT | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.